September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
OncoInfluencers to Follow on Social Media: Dr. Lillian Siu
Sep 5, 2024, 14:03

OncoInfluencers to Follow on Social Media: Dr. Lillian Siu

We are thrilled to spotlight Dr. Lillian Siu as a key figure in the oncology field.

Dr. Lillian Siu is a prominent presence on X/Twitter and LinkedIn, where she shares her deep expertise in oncology and drug development. She currently serves as a Professor of Medicine at the University of Toronto and is a senior medical oncologist at the Princess Margaret Cancer Centre, University Health Network. Her work at these esteemed institutions focuses on advancing cancer treatment and research.

In addition to her clinical and academic roles, Dr. Siu is set to serve as the President-Elect of the American Association for Cancer Research (AACR) for 2024-2025. This prestigious position underscores her leadership and influence in the field of cancer research and treatment.

Follow Dr. Lillian Siu on X/Twitter and LinkedIn to stay informed about her groundbreaking work in oncology and her contributions to advancing cancer research and clinical practice.

About Dr. Lillian Siu

Dr. Lillian Siu is a leading cancer specialist renowned for her expertise in oncology and drug development. As a Professor of Medicine at the University of Toronto and a senior medical oncologist at the Princess Margaret Cancer Centre, University Health Network, she plays a crucial role in advancing cancer treatment and research.

Her leadership extends to her role as the President-Elect of the American Association for Cancer Research (AACR) for 2024-2025. This role highlights her significant impact on the field and her commitment to advancing cancer research and improving patient outcomes.

Dr. Lillian Siu’s extensive experience and leadership continue to drive significant progress in oncology.

Stay tuned for more OncoInfluencers and check out previous profiles on our website to discover other influential voices in the oncology community.